{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:29:09Z","timestamp":1793521749288,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaip.2018.01.025","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T23:21:37Z","timestamp":1517613697000},"page":"776-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-5663","authenticated-orcid":false,"given":"Enrico","family":"Heffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-7188","authenticated-orcid":false,"given":"Lorena Nascimento Girardi","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Puggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-9238","authenticated-orcid":false,"given":"Francesca","family":"Racca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Passalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.01.025_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prrv.2012.05.001","article-title":"From knemometry to final adult height: inhaled corticosteroids and their effect on growth in childhood","volume":"14","author":"de Vreede","year":"2003","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jaip.2018.01.025_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.rmed.2005.11.004","article-title":"Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999)","volume":"100","author":"Neffen","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib3","author":"Global Initiative for Asthma (GINA)"},{"key":"10.1016\/j.jaip.2018.01.025_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11882-012-0325-9","article-title":"Personalised medicine and asthma diagnostics\/management","volume":"13","author":"Wadsworth","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2018.01.025_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.rmed.2005.11.020","article-title":"Systemic side effects of inhaled corticosteroids in patients with asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/JAA.S15081","article-title":"Clinical update on the use of biomarkers of airway inflammation in the management of asthma","volume":"4","author":"Wadsworth","year":"2011","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2018.01.025_bib7","first-page":"329","article-title":"Nonadherence in difficult asthma\u2014facts, myths, and a time to act","volume":"7","author":"Lindsay","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2018.01.025_bib8","first-page":"40","article-title":"Therapeutic interventions in severe asthma","volume":"9","author":"Canonica","year":"2016","journal-title":"WAO J"},{"key":"10.1016\/j.jaip.2018.01.025_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpeds.2014.09.055","article-title":"Inhaled corticosteroids and growth: still an issue after all these years","volume":"166","author":"Allen","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2018.01.025_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12948-015-0016-x","article-title":"Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly","volume":"13","author":"Scichilone","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2018.01.025_bib11","author":"National Institutes of Health, National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program"},{"key":"10.1016\/j.jaip.2018.01.025_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-3038.2007.00540.x","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 1. Which test should be used?","volume":"18","author":"Z\u00f6llner","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-3038.2007.00539.x","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 2\u2014the risk as determined by gold standard adrenal function tests: a systematic review","volume":"18","author":"Z\u00f6llner","year":"2007","journal-title":"Pediat Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1710-1492-7-13","article-title":"Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy","volume":"7","author":"Ahmet","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/0009922812437932","article-title":"Adrenal insufficiency and growth failure secondary to inhaled corticosteroids: a paradoxical complication","volume":"51","author":"Smith","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaip.2018.01.025_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/archdischild-2016-311223","article-title":"Symptomatic adrenal suppression among children in Canada","volume":"102","author":"Goldbloom","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2018.01.025_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamapediatrics.2015.3526","article-title":"Endocrine effects of inhaled corticosteroids in children","volume":"170","author":"Kapadia","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2018.01.025_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/0009922812462235","article-title":"Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature","volume":"51","author":"Schwartz","year":"2012","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.jaip.2018.01.025_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jaip.2018.01.025_bib20","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.jaip.2018.01.025_bib21","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1542\/peds.2012-1147","article-title":"Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children","volume":"130","author":"Z\u00f6llner","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2018.01.025_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clinthera.2006.03.003","article-title":"Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: a comparison of ciclesonide and fluticasone propionate","volume":"28","author":"Kaliner","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2018.01.025_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/archdischild-2012-303105","article-title":"Inhaled corticosteroid and children's growth","volume":"99","author":"Bush","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2018.01.025_bib24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2015.09.039","article-title":"Factors influencing growth effects of inhaled corticosteroids in children","volume":"136","author":"Wolfgram","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib26","doi-asserted-by":"crossref","first-page":"e0133428","DOI":"10.1371\/journal.pone.0133428","article-title":"Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis","volume":"10","author":"Loke","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.01.025_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874306401408010066","article-title":"The effects of inhaled corticosteroids on growth in children","volume":"8","author":"Philip","year":"2014","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jaip.2018.01.025_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40733-016-0020-z","article-title":"Treatment of asthma in young children: evidence-based recommendations","volume":"2","author":"Castro-Rodriguez","year":"2016","journal-title":"Asthma Res Pract"},{"issue":"2","key":"10.1016\/j.jaip.2018.01.025_bib29","first-page":"CD010352","article-title":"Ciclesonide versus other inhaled corticosteroids for chronic asthma in children","author":"Kramer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2018.01.025_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/pch\/20.5.248","article-title":"Inhaled corticosteroids in children with persistent asthma: effects on growth","volume":"20","author":"Kuzik","year":"2015","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jaip.2018.01.025_bib31","first-page":"51","article-title":"Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews","volume":"16","author":"Pruteanu","year":"2015","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jaip.2018.01.025_bib32","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1590\/S0021-75572006000700010","article-title":"Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy","volume":"82","author":"Rizzo","year":"2006","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.jaip.2018.01.025_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1874306401408010085","article-title":"Inhaled corticosteroids and bone health","volume":"8","author":"Chee","year":"2014","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jaip.2018.01.025_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2332\/allergolint.10-OA-0276","article-title":"Assessment of bone status in inhaled corticosteroid user asthmatic patients with an ultrasound measurement method","volume":"60","author":"Sasagawa","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2018.01.025_bib35","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/all.12438","article-title":"Osteoporosis in the at-risk asthmatic","volume":"69","author":"Aljubran","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.01.025_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","article-title":"Glucocorticoid-induced osteoporosis: an update on effects and management","volume":"132","author":"Buehring","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamapediatrics.2017.3579","article-title":"Association between inhaled corticosteroid use and bone fracture in children with asthma","volume":"172","author":"Gray","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2018.01.025_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/2050312115586912","article-title":"Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy setting","volume":"3","author":"Chan","year":"2015","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaci.2005.10.036","article-title":"Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density","volume":"117","author":"Fuhlbrigge","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.01.025_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jaip.2018.01.025_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaip.2018.01.025_bib42","doi-asserted-by":"crossref","first-page":"e3427","DOI":"10.1136\/bmj.e3427","article-title":"Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study","volume":"344","author":"Hippisley-Cox","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2018.01.025_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874306401408010059","article-title":"Systemic effects of inhaled corticosteroids: an overview","volume":"8","author":"Pandya","year":"2014","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jaip.2018.01.025_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874306401408010101","article-title":"Effect of inhaled corticosteroids on glycemic status","volume":"8","author":"Egbuonu","year":"2014","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jaip.2018.01.025_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib46","first-page":"300","article-title":"Hemoglobin a1c levels in children with asthma using low dose inhaled corticosteroids","volume":"46","author":"Yucel","year":"2009","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaip.2018.01.025_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-016-0170-z","article-title":"Transient symptomatic hyperglycaemia secondary to inhaled fluticasone propionate in a young child","volume":"16","author":"Lelii","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjmed.2008.09.048","article-title":"The association of inhaled corticosteroid use with serum glucose concentration in a large cohort","volume":"122","author":"Slatore","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib49","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1183\/09031936.06.00043005","article-title":"Low-dose inhaled and nasal corticosteroid use and the risk of cataracts","volume":"27","author":"Ernst","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2018.01.025_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1370\/afm.517","article-title":"Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes","volume":"4","author":"Gartlehner","year":"2006","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pupt.2015.04.001","article-title":"The risk and outcomes of pneumonia in patients on inhaled corticosteroids","volume":"32","author":"Sibila","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.01.025_bib52","doi-asserted-by":"crossref","first-page":"e1723","DOI":"10.1097\/MD.0000000000001723","article-title":"Inhaled corticosteroids increase the risk of pneumonia in patients with chronic obstructive pulmonary disease: a Nationwide cohort study","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2018.01.025_bib53","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4187\/respcare.02191","article-title":"Effects of inhaled corticosteroid on pneumonia severity and antimicrobial resistance","volume":"58","author":"Sibila","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.jaip.2018.01.025_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/CPM.0b013e31827a2a60","article-title":"The paradoxical effect on pneumonia of chronic inhaled corticosteroids","volume":"20","author":"Sibila","year":"2013","journal-title":"Clin Pulm Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1183\/09031936.00077509","article-title":"Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia","volume":"36","author":"Malo de Molina","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2018.01.025_bib56","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1378\/chest.13-0871","article-title":"Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study","volume":"144","author":"McKeever","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2018.01.025_bib57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib58","first-page":"971","article-title":"Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis","volume":"6","author":"Ni","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaip.2018.01.025_bib59","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/thoraxjnl-2012-203175","article-title":"Use of inhaled corticosteroids and the risk of tuberculosis","volume":"68","author":"Lee","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2018.01.025_bib60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib61","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.01.025_bib62","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jaip.2018.01.025_bib63","first-page":"CD003559","article-title":"Omalizumab for asthma in adults and children","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818300527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818300527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:19Z","timestamp":1761973999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818300527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2213219818300527"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.01.025","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}